It is estimated that in the European Community in 2005 there were 195 million women
over 15 years of age, of whom:

  • 15.5 million women were carriers of HPV DNA.
  • 2 million women with acuminate conditions (AC)
  • 2 million with low grade squamous epithelial lesions (LSIL)
  • 95,000 women with epi – High-grade squamous cell (HSIL)

As a result, it can be estimated that 20 million women over 15 years of age, out of 195 million registered in the European Union (10.3% of the population in this age group), have at some time in their lives a genital condition, clinical or subclinical, attributable to HPV infections or any of its neoplasms.

Among the most recent studies carried out in Spain, we highlight:

A random sample of 973 women, mostly monogamous, with an average age of 43 years (+/- 16 years) and a prevalence of 3%.

A study of 1,368 women who attended a gynecological or family planning visit showed an overall prevalence of 8.3%, of which the majority (87%) of the women were high-risk HPV, with age groups of:
< 30 years: 11.2%
30 – 49 years: 7.2%
> 50 years: 3.4%.

    • The human papillomavirus represents one of the most common sexually  transmitted infections.
    • Infection of the virus tends to cure in 90% of cases.
    • Sexually active young people aged 18 to 25 are considered to be HPV positive.
      In most cases it is an infection that has no symptoms.
    • In the developing countries cervical cancer is the most common cancer.
    • In Spain cervical cancer is the second most frequent gynecological cancer.